Ipamorelin
Selective GH release without the cortisol spike
- Format
- Research vial
- Strength / pack
- 5mg vial
- Category
- Performance
Related research
CJC-1295 + Ipamorelin
A two-peptide blend pairing the GHRH analog CJC-1295 (without DAC / Modified GRF 1-29) with the selective ghrelin-receptor agonist Ipamorelin. CJC-1295 lifts the baseline of pulsatile GH release; Ipamorelin amplifies pulse amplitude without driving cortisol, prolactin or ACTH. Dual-receptor stimulation produces a GH response greater than the sum of either alone.
Hexarelin
Hexarelin is a synthetic hexapeptide analog of GHRP-6 and a potent agonist of the growth-hormone-secretagogue receptor (GHS-R1a). It also binds the non-GHS-R receptor CD36, which underlies a separate cardiac action that does not depend on GH release. Of the older GHRPs it produces the strongest GH pulse.
IGF-1 LR3
IGF-1 LR3 (Long R3 IGF-1) is an 83-amino-acid synthetic analog of insulin-like growth factor 1 with a 13-residue N-terminal extension and an arginine substituted for glutamic acid at position 3. The Arg-3 substitution drops affinity for IGF binding proteins ~100-fold while preserving full IGF-1 receptor agonism, so more of the injected peptide is free to bind tissue.